Evidence map›Paper›PMID 16537379›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Transient receptor potential vanilloid 4 regulates aquaporin-5 abundance under hypotonic conditions.

Venkataramana K Sidhaye, Ali D Güler, Kelly S Schweitzer, Franco D'Alessio, Michael J Caterina, Landon S King

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 110 citations in OpenAlex.

  1. Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise.American journal of physiology. Regulatory, integrative and comparative physiology · 2014
    Trial
  2. Article
  3. Article
  4. Review
  5. Regulation of Neural Functions by Brain Temperature and Thermo-TRP Channels.Advances in experimental medicine and biology · 2024
    Review
  6. Review
  7. Article
  8. Physiological Cooperation between Aquaporin 5 and TRPV4.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. CaCells · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. TRPV4 activation by thermal and mechanical stimuli in disease progression.Laboratory investigation; a journal of technical methods and pathology · 2020
    Review
  19. Ions, the Movement of Water and the Apoptotic Volume Decrease.Frontiers in cell and developmental biology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Venkataramana K SidhayeDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Ali D Güler
Kelly S Schweitzer
Franco D'Alessio
Michael J Caterina
Landon S King
Pulmonary and Critical Care Associates · USJohns Hopkins University · US

Funding

Role of TRPV channels in pain and temperature sensationR01NS051551 · NINDS · JOHNS HOPKINS UNIVERSITY · PI CATERINA, MICHAEL J · 2005 to 2009
$1.6M
Molecular and Cellular Analyses of Aquaporins in LungR01HL070217 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KING, LANDON S · 2002 to 2005
$1.2M
cCAMP Regulation of Aquaporin 5F32HL074515 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SIDHAYE, VENKATARAMANA K · 2003 to 2004
$102k
NHLBI NIH HHS F32 HL 074515NHLBI NIH HHS F32 HL074515NHLBI NIH HHS R01 HL070217NHLBI NIH HHS R01 HL 70217NINDS NIH HHS 1R01 NS 051551-01NINDS NIH HHS R01 NS051551
6 · The paper itself

Abstract

Aquaporin-5 (AQP5) is expressed in epithelia of lung, cornea, and various secretory glands, sites where extracellular osmolality is known to fluctuate. Hypertonic aquaporin (AQP) induction has been described, but little is known about the effects of a hypotonic environment on AQP abundance. We report that, when mouse lung epithelial cells were exposed to hypotonic medium, a dose-responsive decrease in AQP5 abundance was observed. Hypotonic reduction of AQP5 was blocked by ruthenium red, methanandamide, and miconazole, agents that inhibit the cation channel transient receptor potential vanilloid (TRPV) 4 present in lung epithelial cells. Several observations indicate that TRPV4 participates in hypotonic reduction of AQP5, including a requirement for extracellular calcium to achieve AQP5 reduction; an increase in intracellular calcium in mouse lung epithelial (MLE) cells after hypotonic stimulation; and reduction of AQP5 abundance after addition of the TRPV4 agonist 4alpha-Phorbol-12,13-didecanoate (4alpha-PDD). Similarly, addition of hypotonic PBS to mouse trachea in vivo decreased AQP5 within 1 h, an effect blocked by ruthenium red. To confirm a functional interaction, AQP5 was expressed in control or TRPV4-expressing human embryonic kidney (HEK) cells. Hypotonic reduction of AQP5 was observed only in the presence of TRPV4 and was blocked by ruthenium red. Combined with earlier studies, these observations indicate that AQP5 abundance is tightly regulated along a range of osmolalities and that AQP5 reduction by extracellular hypotonicity can be mediated by TRPV4. These findings have direct relevance to regulation of membrane water permeability and water homeostasis in epithelia of the lung and other organs.

Indexed as

AnimalsAquaporin 5Biological TransportCalciumCell MembraneDown-RegulationEpithelial CellsHumansHypotonic SolutionsLungMaleMiceMice, Inbred C57BLOsmotic PressurePermeabilityPhorbol Esters12-deoxyphorbol-13-decanoateAquaporin 5CalciumHypotonic SolutionsPhorbol EstersRuthenium RedTRPV4 protein, humanTRPV Cation ChannelsWater

Identifiers

PMID16537379
PMCPMC1450241
OpenAlexW2000616741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.